Alan List

President & Chief Executive Officer at H. Lee Moffitt Cancer Center and Research Institute, Inc.

Alan List

Alan List

President & Chief Executive Officer at H. Lee Moffitt Cancer Center and Research Institute, Inc.

Overview
Career Highlights

H. Lee Moffitt Cancer Center & Research Inst Foundation
H. Lee Moffitt Cancer Center and Research Institute, Inc.

RelSci Relationships

2816

Number of Boards

10

Relationships
RelSci Relationships are individuals Alan List likely has professional access to. A relationship does not necessarily indicate a personal connection.

Professor, Division of Hematology & Oncology at University of California, Irvine - School of Medicine

Relationship likelihood: Strong

Vice President & Associate Cancer Center Director of Translational Research at City of Hope - California

Relationship likelihood: Strong

Founder at H. Lee Moffitt Cancer Center and Research Institute, Inc.

Relationship likelihood: Strong

Founder at M2Gen Corp.

Relationship likelihood: Strong

Director at Oregon Health & Science University - Knight Cancer Institute

Relationship likelihood: Strong

Independent Consultant at Cornerstone Pharmaceuticals, Inc.

Relationship likelihood: Strong

Executive Director at Myelodysplastic Syndromes Foundation

Relationship likelihood: Strong

Professor, Oncology at University of South Florida - Morsani College of Medicine

Relationship likelihood: Strong

Laurence Joseph Dineen Chair in Leukemia Research at Memorial Sloan-Kettering Cancer Center

Relationship likelihood: Strong

Chief Executive Officer at University of South Florida System

Relationship likelihood: Strong

Paths to Alan List
Potential Connections via
Relationship Science
You
Alan List
President & Chief Executive Officer at H. Lee Moffitt Cancer Center and Research Institute, Inc.
Education
MD

The University of Pennsylvania is the oldest and one of the finest medical schools in the United States. Penn is rich in tradition and heritage and at the same time consistently at the forefront of new developments and innovations in medical education and research. Since its founding in 1765 the School has been a strong presence in the community and prides itself on educating the leaders of tomorrow in patient care, biomedical research, and medical education. At Penn academic excellence, as well as compassion for the patients we are privileged to serve, are stressed. Skillful compassion is truly a hallmark of the Penn learning experience. The Perelman School of Medicine at the University of Pennsylvania consistently ranks among the top five in US News and World Report’s rankings of research-oriented medical schools.

Memberships
Member
Current

American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.

Member
Current

The American Society of Hematology 's mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.

Member
Current

The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology.American Society of Clinical Oncology is the world's leading professional organization representing physicians who treat people with cancer. ASCO's members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research.

Career History
President & Chief Executive Officer
2003 - Current

Moffitt Cancer Center in Tampa, Florida, has made a lasting commitment to the prevention and cure of cancer, working tirelessly in the areas of patient care, research and education to advance one step further in fighting this disease. Alan F. List, M.D. President/CEO Translational Research As part of an elite group of National Cancer Institute (NCI) Comprehensive Cancer Centers, Moffitt focuses on the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. Tradition of Excellence Since our first patient admission in October 1986, Moffitt physicians, scientists and staff members have worked together to establish a tradition of excellence offered in an atmosphere characterized by kindness, caring and hope. Our future growth in clinical care and research rests firmly on this tradition and makes possible the changes ahead. Mission The mission of Moffitt Cancer Center is to contribute to the prevention and cure of cancer. Vision Our vision is "to be the leader in scientific discovery and translation into compassionate care, cures, and prevention of cancer for our community and the world." As we grow to fulfill our mission, we will continue to be distinguished by our compassionate and effective patient care. Institutional Values S cientific, educational, and patient care excellence U nity in pursuit of our mission C reativity C ompassion for our patients and their families E mployees, volunteers, and faculty are our most prized resources S tewardship S ocial responsibility and ethics of the highest standard Moffitt Facts Moffitt Cancer Center is a not-for-profit institution. It includes private patient rooms, the Southeast’s largest Blood and Marrow Transplant Program, outpatient treatment programs that record more than 328,300 visits a year, the Moffitt Research Center, Moffitt Cancer Center at International Plaza, and Moffitt Cancer Center Screening and Prevention. In 2003, Moffitt opened its doors to the Muriel Rothman Building (Clinic) and Vincent A. Stabile Research Building. These two buildings dramatically increased the existing research and outpatient clinical space to better serve our patients.

President
Tenure Unconfirmed

The Moffitt Cancer Center Foundation is a tax-exempt charitable organization under the section 501 (c)(3) of the Internal Revenue Code, and is authorized to accept charitable gifts and supports patient care, research and education on behalf of H. Lee Moffitt Cancer Center & Research Institute. They contribute to the prevention and cure of cancer. The company was founded in 1994 and is located in Tampa, FL.

Professor of Internal Medicine & Oncology
Tenure Unconfirmed

University of South Florida College of Medicine is one of the graduate schools of the University of South Florida located in Tampa, Florida.

Boards & Committees
Chair, Scientific Advisory Board
2015 - Current

Cellular Biomedicine Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. Its technology includes immune system therapy for treatment of cancer indications and human adipose-derived mesenchymal progenitor cells (haMPC) for treatment of joint and autoimmune diseases. The company was founded in 2009 and is headquartered in New York, NY.

Member, Clinical Advisory Board
Tenure Unconfirmed

TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. The firm focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases. Its products include Birinapant and SHAPE. The company was founded by Yigong Shi, John M. Gill and Mark A. McKinlay in July 2001 and is headquartered in Malvern, PA.

Member, Board of Directors
Current

The MDS Foundation is an international organization devoted to patient support, research, treatment, and education in the myelodysplastic syndromes (MDS). The Foundation is based on the premise that international cooperation will accelerate the process leading to the control and cure of MDS. The Foundation, through our network of Centers of Excellence worldwide, provides referrals for patients, disseminates information on research and treatments, provides educational programs for physicians, nurses, pharmacists and patients, and supplies funding/oversight for international studies in MDS.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1,000 - $4,999
2011

The Conquer Cancer Foundation was founded by the foremost cancer doctors of the American Society of Clinical Oncology (ASCO) to seek dramatic advances in the prevention, treatment, and cures of all types of cancer. ASCO was created in 1964 by seven cancer physicians with a single purpose: to improve the care of people with cancer. ASCO has grown from its original seven members to nearly 45,000 today representing over 120 countries. As its foundation, Conquer Cancer helps support ASCO's many programs and activities, including cancer research, learning opportunities for oncology professionals, patient and caregiver education, and more.

Political Donations
$1,000
2016

Representative from Florida's 14th Congressional District

$1,000
2014

Representative from Florida's 14th Congressional District

$500
2009

Representative from Florida's 14th Congressional District

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Alan List. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Alan List's profile does not indicate a business or promotional relationship of any kind between RelSci and Alan List.